Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development and commercialization of...

Related Keywords

,European Medicines Agency ,Eiger Biopharmaceuticals Inc ,Compensation Committee Of Eiger Board Directors ,Nasdaq ,Eiger Biopharmaceuticals ,Erik Atkisson ,General Counsel ,Chief Compliance Officer ,Compensation Committee ,Nasdaq Listing Rule ,Hepatitis Delta Virus ,Hutchinson Gilford Progeria Syndrome ,Marketing Authorization Application ,Nc ,Biotechnology ,Pharmaceuticals ,Medical Pharmaceuticals ,Health Care Amp Hospitals ,